Schedule 13G ownership disclosure
DiaMedica Therapeutics Inc
Voting Common Shares, no par value · CUSIP: 25253X207
Event date: 2025-12-31
- Filing-level shares
- 3,450,000
- Percent of class
- 6.6%
- Cooperman Leon G.
Shares: 3,450,000 · Class: 6.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000945621-26-000352
- Form type
- SCHEDULE 13G/A
- Filer
- COOPERMAN LEON G
- CIK
- CIK 898382
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership